Nutra Pharma’s Nyloxin claims to relieve cancer pain and potentially help treat opioid addiction, among others, mark its products as unapproved new drugs, FDA asserts in a warning letter that reflects its homeopathic enforcement approach proposed in late 2017.  “Health fraud scams like these are inexcusable,” says FDA Commissioner Scott Gottlieb.

FDA advised Hanna’s Herb Shop to discontinue drug claims for more than a dozen Kroeger herbal supplements, including “decrease dementia” or tackle “hypertension.” Separately, agency sets a date for its “Responsible Innovation” meeting for regulating the vitamin, mineral and supplement industry.